Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy.

In terms of treatment prognosis, regardless of the therapeutic options, patients with pachychoroid had better outcome in VA at all follow-up time points, although the differences did not reach statistical significance.

also in 111,027 other papers